Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 13:13:2111-2118.
doi: 10.2147/PPA.S231873. eCollection 2019.

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia

Monira Alwhaibi  1   2 , Maha Altoaimi  3 , Yazed AlRuthia  1   4 , Abdulkarim M Meraya  5   6 , Bander Balkhi  1   2 , Ahmed Aldemerdash  1 , Hadeel Alkofide  1 , Tariq M Alhawassi  1   2 , Abdulmajeed Alqasoumi  3 , Khalid M Kamal  7
Affiliations

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia

Monira Alwhaibi et al. Patient Prefer Adherence. .

Abstract

Background: Statins are widely utilized antidyslipidemics with a proven track record of safety and efficacy. However, the efficacy of these therapeutic agents hinges on patients' adherence to their prescribed statins.

Objective: The primary objectives of this study were to examine the relationship between adherence to prescribed statins and its impact on the low-density lipoprotein (LDL) level, and to explore the factors that influence patient adherence to statins among patients with diabetes and dyslipidemia.

Methods: This was a retrospective, cross-sectional study using the electronic health records data of adults (≥18 years) with type 2 diabetes and dyslipidemia visiting outpatient clinics at a university-affiliated tertiary care center. Adherence to statin therapy was estimated using the proportion of days covered (PDC). Patients with diabetes were considered adherent to statins if they had a PDC of ≥80%. Treatment success was considered if the LDL level of < 2.6 mmol/L.

Results: Out of 10,226 of patients with diabetes, 1532 met the inclusion criteria and were included in the study. Seventy-nine percent of the patients with diabetes were on atorvastatin and 21% were on simvastatin. The vast majority of the patients with diabetes (77%) were considered adherent and about 42% achieved LDL-cholesterol goal < 2.6 mmol/L. No association between adherence to statin therapy and LDL goal attainment was observed. Women had lower odds of being adherent to statin therapy (AOR=0.66, 95% CI: 0.49-0.87) compared to men. Further, young adults (18-44 years) had lower odds of being adherent to statin therapy (AOR=0.58, 95% CI: 0.32-0.97) compared to older adults (age>65 years).

Conclusion: The findings of this study highlight the need to examine the impact of adherence to statins on healthcare services utilization due to different complications of uncontrolled dyslipidemia.

Keywords: adherence; diabetes; dyslipidemia; low-density lipoprotein cholesterol; statins.

PubMed Disclaimer

Conflict of interest statement

Dr Khalid Kamal report grants from Novartis, grants from Johnson and Johnson, outside the submitted work. The authors report no other conflicts of interest in this work.

References

    1. Al-Kaabba AF, Al-Hamdan NA, El Tahir A, Abdalla AM, Saeed AA, Hamza MA. Prevalence and correlates of dyslipidemia among adults in Saudi Arabia: results from a national survey. Open J Endocr Metab Dis. 2012;2:89. doi:10.4236/ojemd.2012.24014 - DOI
    1. Al-Nozha MM, Arafah MR, Al-Maatouq MA, et al. Hyperlipidemia in Saudi Arabia. Saudi Medi J. 2008;29:282–287. - PubMed
    1. Ogbeide DO, Karim A, Al-Khalifa IM, Siddique S. Population based study of serum lipid levels in Al-Kharj Health Center, Saudi Arabia. Saudi Med J. 2004;25:1855–1857. - PubMed
    1. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. World Health Organization; 2002. - PubMed
    1. Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–2497. doi:10.1001/jama.285.19.2486 - DOI - PubMed